Transcept announces Intermezzo tablet preliminary data for insomnia

Download PDF Copy

Oct 19 2010

NewsGuard 100/100 Score

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced its preliminary analysis of data from the recently completed Intermezzo® 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.

Transcept is developing Intermezzo® for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep. In the Intermezzo® New Drug Application (NDA), Transcept proposed to the U.S. Food and Drug Administration (FDA) that patients have at least four hours remaining in bed after dosing Intermezzo® in the middle of the night.

Source:

Transcept Pharmaceuticals, Inc.

Posted in: Drug Trial News | Medical Condition News

Tags: Epidemiology, Food, Hospital, Insomnia, Neuroscience, New Drug Application, Obsessive Compulsive Disorder, Pharmaceuticals, Psychopharmacology, Sleep

Comments (0)

Download PDF Copy

Suggested Reading

Iron deficiency linked to restless sleep in ADHD and autism

Iron deficiency linked to restless sleep in ADHD and autism

Study suggests NSAIDs may lower postoperative delirium risk

Study suggests NSAIDs may lower postoperative delirium risk

How physical activity and diet impact sleep in adolescents

How physical activity and diet impact sleep in adolescents

Poor sleep before surgery linked to increased risk of postoperative delirium

Poor sleep before surgery linked to increased risk of postoperative delirium

Addressing the physical health risks related to excessive video gaming

Addressing the physical health risks related to excessive video gaming

Expert survey unveils underestimated health impacts of weather and climate on mortality

Expert survey unveils underestimated health impacts of weather and climate on mortality

Cognitive behavioral therapy for insomnia linked to reduced postpartum depression

Cognitive behavioral therapy for insomnia linked to reduced postpartum depression

Artificial nighttime light increases insomnia risk, especially in smaller cities

Artificial nighttime light increases insomnia risk, especially in smaller cities

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Researchers aim to transform treatment for sleep disorders in military personnel